Synbiotics in health and disease

Annual Review of Food Science and Technology

Volumn 2, Issue , 2011, Pages 373-393

  Kolida, Sofia ^a   Gibson, Glenn R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

cancer; gut flora; inflammatory bowel disease (IBD); irritable bowel syndrome (IBS); prebiotic; probiotic

Indexed keywords

CANCER; GUT FLORA; INFLAMMATORY BOWEL DISEASE; IRRITABLE BOWEL SYNDROMES; PREBIOTICS; PROBIOTICS;

FOOD TECHNOLOGY;

HEALTH;

BACTERIA (MICROORGANISMS);

SYNBIOTIC AGENT;

ANIMAL; COLON TUMOR; DIET THERAPY; ENTERITIS; HEALTH PROMOTION; HUMAN; INTESTINE; IRRITABLE COLON; MICROBIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW;

ANIMALS; COLONIC NEOPLASMS; HEALTH PROMOTION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; IRRITABLE BOWEL SYNDROME; POSTOPERATIVE COMPLICATIONS; SYNBIOTICS;

EID: 84855363386     PISSN: 19411413     EISSN: 19411421     Source Type: Journal    
DOI: 10.1146/annurev-food-022510-133739     Document Type: Article

References (78)

1. Alaradi O, Barkin JS. 2002. Irritable bowel syndrome: update on pathogenesis and management. Med. Princ. Pract. 11(1):2-17
2. Anderson AD, McNaught CE, Jain PK, MacFie J. 2004. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53(2):241-45
3. Aragon-AlegroLC, Alegro JHA, Cardarelli HR,ChiuMC, Saad SMI. 2007. Potentially probiotic and synbiotic chocolate mousse. LWT 40:669-75
4. Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT. 2005. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin. Infect. Dis. 40(1):28-37
5. Bangmark S. 2004. Bio-ecological control of perioperative and ITU morbidity. Langenbecks Arch Surg. 389:145-154
6. Bianchini F, Kaaks R, Vainio H. 2002. Overweight, obesity, and cancer risk. Lancet Oncol. 3(9):565-74
7. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, et al. 2005. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100:1539-46
8. Bingham SA, Norat T,Moskal A, Ferrari P, Slimani N, et al. 2005. Is the association with fibre from foods in colorectal cancer confounded by folate intake? Cancer Epidemiol. Biomarkers Prev. 14:1552-56
9. Buriti FCA, Cardarelli HR, Filisetti TMCC, Saad SMI. 2007. Synbiotic potential of fresh cream cheese supplemented with inulin and Lactobacillus paracasei in co-culture with Streptococcus thermophilus. Food Chem. 104:1605-10
10. Burns AJ, Rowland IR. 2004. Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat. Res. 551(1-2):233-43 Cancer research UK. 2005. Cancer stats: Lifestyle and cancer. (http://info.cancerresearchuk.org/ cancerstats/)
11. Cancer research UK. 2006. Cancer stats: Large bowel cancer - UK. (http://info.cancerresearchuk. org/cancerstats/)
12. Cardarelli HR, Buriti FCA, Castro IA, Saad AMI. 2008. Inulin and oligofructose improve sensory quality and increase the probiotic viable count in potentially synbiotic petit-suisse cheese. Food Sci. Technol. 41(6):1037-46
13. Casiraghi MC, Canzi E, Zanchi R, Donati E, Villa L. 2007. Effects of a synbiotic milk product on human intestinal ecosystem. J. Appl. Microbiol. 103(2):499-506
14. Chermesh I, Tamir A, Reshef R, Chowers Y, Suissa A, et al. 2007. Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig. Dis. Sci. 52:385-89
15. Crittenden R, Weerakkody R, Sanguansri L, Augustin M. 2006. Synbiotic microcapsules that enhance microbial viability during nonrefrigerated storage and gastrointestinal transit. Appl. Environ. Microbiol. 72(3):2280-82
16. Crittenden RG, Morris LF, Harvey ML, Tran LT, Mitchell HL, Playne MJ. 2001. Selection of a bifidobacterium strain to complement resistant starch in a synbiotic yoghurt. J. Appl. Microbiol. 90(2):268-78
17. De Preter V, Vanhoutte T, Huys G, Swings J, De Vuyst L, Rutgeerts P, Verbeke K. 2007. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am. J. Physiol. Gastrointest. Liver Physiol. 292(1):G358-68
18. Desai AR, Powell IB, Shah NP. 2004. Survival and activity of probiotic lactobacilli in skim milk containing prebiotics. J. Food Sci. 69(3):M57-60
19. Dughera L, Elia C, Navino M, Cisar̀o F. 2007. Effects of synbiotic preparations on constipated irritable bowel syndrome symptoms. Acta Biomed. 78(2):111-16
20. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, et al. 2001. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am. J. Clin. Nutr. 73(Suppl.):386S- 92
21. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, et al. 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23(11):1953-60
22. Fujimori S, Tatsuguchi A, Gudis K, Kishida T, Mitsui K, et al. 2007. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. J. Gastroenterol. Hepatol. 22(8):1199-204
23. Fuller R. 1991. Probiotics in human medicine. Gut 32:432-42
24. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, et al. 2005. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54:242-49
25. Gallaher DD, Khil J. 1999. The effect of synbiotics on colon carcinogenesis in rats. J. Nutr. 129(7 Suppl.):1483S-87
26. Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125(6):1401-12
27. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, et al. 2010. Dietary prebiotics: current status and new definition. IFIS 7(1):1-19
28. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, et al. 2003. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124:1202-9
29. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, et al. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:305-9
30. GottelandM, Poliak L, Cruchet S, Brunser O. 2005. Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori. Acta Paediatr. 94(12):1747- 51
31. Havenaar R, Huis In't Veld MJH. 1992. Probiotics, a general view. In Lactic Acid Bacteria in Health and Disease. Vol. 1, ed. BJWood, pp. 151-70. Amsterdam: Elsevier
32. Homayouni A, Azizi A, Ehsani MR, Yarmand MS, Razavi SH. 2008. Effect of microencapsulation and resistant starch on the probiotic survival and sensory properties of synbiotic ice cream. Food Chem. 111(1):50-55
33. Iyer C, Kailasapathy K. 2005. Effect of co-encapsulation of probiotics with prebiotics on increasing the viability of encapsulated bacteria under in vitro acidic and bile salt conditions and in yogurt. J. Food Sci. 70(1):M18-23
34. FAO/WHO. 2002. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Can.: WHO
35. Kajander K, Hatakka K, Poussa T, FǎrkkilǎM,Korpela R. 2005. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment. Pharmacol. Ther. 22(5):387- 94
36. Kanamori Y, Hashizume K, Kitano Y, Tanaka Y, Morotomi M, et al. 2003. Anaerobic dominant flora was reconstructed by synbiotics in an infant with MRSA enteritis. Pediatr. Int. 45:359-62
37. Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, et al. 2004. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J. Ped. Surg. 39:1686-92
38. Klinder A, Forster A, Caderni G, Femia AP, Pool-Zobel BL. 2004. Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr. Cancer. 49(2):144-55
39. Kuisma J, Mentula S, Jarvinen H, Kahri A, Saxelin M, Farkkila M. 2003. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment. Pharmacol. Ther. 17:509-15
40. Le Leu RK, Brown IL, Hu Y, Bird AR, Jackson M, et al. 2005. A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J. Nutr. 135(5):996-1001
41. Lilly DM, Stillwell RH. 1965. Probiotics: growth promoting factors produced by microorganisms. Science 147:747-48
42. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, et al. 2004. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39(5):1441-49
43. MacFie J. 1997. Bacterial translocation in surgical patients. Ann. R. Coll. Surg. Engl. 79(3):183-89
44. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, et al. 1999. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45(2):223-28
45. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. 1996. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38:365-75
46. Marshall JC, ChristouNV, Meakins JL. 1993. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann. Surg. 218(2):111-19
47. Mattila-Sandholm T, Myllǎrinen P, Crittenden R, Mogensen G, Fondén R, Saarela M. 2002. Technological challenges for future probiotic foods. Int. Dairy J. 12:173-82
48. Maybery JF, Probert CSJ, Jayanthi V, Shivananda S. 1991. Epidemiology of inflammatory bowel disease: a European perspective. In Inflammatory Bowel Disease, ed. AA Anagnostides, HJF Hodgson, JB Kirsner, p. 163. London: Chapman and Hall
49. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, et al. 2004. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53:108-14
50. Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, et al. 2004. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int. J. Obes. Relat. Metab. Disord. 28(4):559-67
51. Morelli L, Garbagna N, Rizzello F, Zonenschain D, Grossi E. 2006. In vivo association to human colon of Lactobacillus paracasei B21060: map from biopsies. Dig. Liver Dis. 38(12):894-98
52. Morelli L, Zonenschain D, Callegari ML,Grossi E, Maisano F, Fusillo M. 2003. Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora. Nutr. J. 9:2-11
53. Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ. 2000. Body mass index and colon cancer mortality in a large prospective study. Am. J. Epidemiol. 152(9):847-54
54. Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, et al. 2005. Meat, fish, and colorectal cancer risk: the European prospective investigation into cancer and nutrition. J. Natl. Cancer Inst. 97:906-16
55. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, et al. 2005. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128:541-51
56. Osman N, Adawi D, Molin G, Ahrne S, Berggren A, Jeppsson B. 2006. Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol. 28:6:31
57. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N. 2009. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br. J. Nutr. 101(3):367-75
58. Park Y, Hunter DJ, Spiegelman D, BergkvistL, Berrino F, et al. 2005. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 294(22):2849-57
59. Parker RB. 1974. Probiotics, the other half of the antibiotic story. Anim. Nutr. Health 29:4-8
60. Pathmakanthan S, Thornley JP, Hawkey CJ. 1999. Mucosally associated bacterial flora of the human colon and species-specific differences between normal and inflamed colonic biopsies. Microb. Ecol. Health Dis. 11:169-74
61. Perez-Conesa D, Lopez G, Abellan P, Ros G. 2006. Bioavailability of calcium, magnesium and phosphorus in rats fed probiotic, prebiotic and synbiotic powder follow-up infant formulas and their effect on physiological and nutritional parameters. J. Sci. Food Agric. 86:2327-36
62. Perez-Conesa D, LopezG, Ros G. 2007. Effects of probiotic, prebiotic and synbiotic follow-up infant formulas on large intestine morphology and bone mineralisation in rats. J. Sci. Food Agric. 87(6):1059-68
63. Pineiro M, Asp NG, Reid G, Macfarlane S, Morelli L, et al. 2008. FAO technical meeting on prebiotics. J. Clin. Gastroenterol. 42(Suppl. 3)2:S156-59
64. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, et al. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85(2):488-96
65. Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, et al. 2007. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann. Surg. 246(1):36-41
66. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, et al. 2005. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation: a randomized, double-blind trial. Am. J. Transplant. 5(1):125-30
67. Roberfroid M. 2007. Prebiotics: the concept revisited. J. Nutr. 137(3 Suppl. 2):830S-37
68. Rowland IR, Rumney CJ, Coutts JT, Lievense LC. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19:281-85
69. Salminen S. 1996. Uniqueness of probiotic strains. IDF Nutr. News. Lett. 5:16-18
70. Sartor RB. 1997. The influence of normalmicrobial flora on the development of chronic mucosal inflammation. Res. Immunol. 148:567-76
71. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, et al. 2006. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann. Surg. 244(5):706-14
72. Tanaka R, Takayama H, Morotomi M, Kuroshima T,Ueyama S, et al. 1983. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobact. Microflora 2:17-24
73. Tannock GW. 1998. Studies on the intestinal microflora: a prerequisite for the development of probiotics. Int. Dairy J. 8:527-33
74. Tomoda T, Nakano Y, Kageyama T. 1991. Effect of yogurt and yogurt supplemented with Bifidobacterium and/or lactulose in healthy persons: a comparative study. Bifidobact. Microflora. 10(2):123-30
75. Vanhoutte T, De Preter V, De Brandt E, Verbeke K, Swings J, Huys G. 2006. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl. Environ. Microbiol. 72(9):5990-97
76. Veltkamp C, Tonkonogy SL, De Jong YP, Albright C, Grenther WB, et al. 2001. Continuous stimulation by normal bacteria is essential for the development and perpetuation of colitis in Tge26mice. Gastroenterology 120:900-13
77. Vergin F. 1954. Anti- und probiotika. Hippokrates 25:16-119
78. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, et al. 2006. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol. 101:1581-90